You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
SAN FRANCISCO (GenomeWeb) – A noninvasive test for recessive single-gene disorders could be used to screen prenatally for rare, inherited diseases for which one of the parents is a known carrier, according to researchers at Stanford University.
360Dx Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
You may already have institutional access!
Check if I qualify.
Already a 360Dx or GenomeWeb Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care.